Continuous local injection of carboplatin into the uterine cervix for cervical and endometrial cancer: Preliminary study

Gynecologic and Obstetric Investigation

Volumn 44, Issue 3, 1997, Pages 196-199

  Tsuda, Hiroshi ^a   Yamamoto, Kumio ^a   Kawabata, Masami ^a   Lee, Touman ^a   Hidaka, Atsuo ^a  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

Carboplatin; Continuous local injection; Tissue platinum concentration; Uterine cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG TISSUE LEVEL; ENDOMETRIUM CANCER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; NAUSEA; PELVIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX; UTERINE CERVIX CANCER; VAGINA;

EID: 0030721695     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291519     Document Type: Article

References (13)

1. Alders JG, Abelar V, Kolstad P: Recurrent adenocarcinoma of the endometrium: A clinical and histopathological study of 379 patients. Gynecol Oncol 1984; 17:85-90.
2. Herbst AL: Malignant diseases of the cervix; in Herbst AL, Mishell DR, Stenchever MA, Droe-gemueller W (eds): Comprehensive Gynecology, ecd 2. Philadelphia. Mosby Year Book, 1992, pp 861-894.
3. Park RC, Grigsby PW, Muss HB et al: Corpus: Epithelial tumors; in Hoskins WJ, Perez CA, Young RC (eds): Principles and Practice of Gynecologic Oncology. Philadelphia, Lippincott. 1992, pp 663-694.
4. Perez CA, Kurman RJ, Stcbman FB et al: Uterine cervix; in Hoskins WJ, Perez CA. Young RC (eds): Principles and Practice of Gynecologic Oncology. Philadelphia, Lippincott, 1992, pp 591-662.
5. Jodrell DI. Egorin MJ, Canetta RM: Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J Clin Oncol 1992;10:520-528.
6. Litterst CL, Gram TE, Dedrick RL et al: Distribution and disposition of platinum following intravenous administration of cw-diamminc-dichloroplatinum(II) (NSC 119875) to dogs. Cancer Res 1976;36:2340-2344.
7. l95mPt)carbopla-tin following intravenous, intraperitoneal and oral administration. Nucl Med Biol 1990:17: 427-436.
8. Takebayashi T, Fujino Y, Umcsaki N et al: Danazol suspension injected into the uterine cervix of patients with adenomyosis and myoma: Preliminary study. Gynecol Obstet Invest 1995;39:207-211.
9. Smith EF. Willcmsc PHB, Sleijfer DT et al: Continuous infusion carboplatin on a 21-day schedule: A phase 1 and pharmacokinetic study. J Clin Oncol 1991;9:100-110.
10. Hecquet B, Vennin P, Fournier C et al: Platinum concentration in human tumors of head and neck, uterine cervix, and breast following treatment with cisplatin. Cancer Chcmothcr Pharmacol 1985;15:310-312.
11. Gouyette A, Apchin A, Foka M et al: Pharmacokinetics of intra-arterial and intravenous cisplatin in head and neck cancer patients. Eur J Cancer Clin Oncol 1986;22:257-263.
12. Vennin P, Hecquet B. Poissonnier B et al: Comparative study of intravenous and intraarterial «.y-platinum on intratumoral platinum concentration in carcinoma of the cervix. Gynecol Oncol 1989;32:180-183.
13. Los G, Verdegaal EME, Mutsaers PHA et al: Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy. Cancer Chemothcr Pharmacol 1991;28:159-165.